DOI : 10.1055/s-00000059

Pneumologie

Issue S 01 · Volume 79 · March 2025 DOI: 10.1055/s-015-61381


65. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.
Leipzig, 09.–12.04.2025

Kongresspräsidenten:
Prof. Dr. Dirk Koschel
Abstracts (HTML) Abstracts (PDF) List of Authors
  • FV 121
    Elfeturi, M; Barth, M; Gorol, O; Jörn, B; Hidalgo Pareja, D; Rach, P; Ratsimba, F; Regmi, B; Thomer, J; Wagner, F; Yousef, S; Kühnel, M; Dreher, M; Spiesshoefer, J:

    Atemmuskelkraft als Marker für Asthmakontrolle: Signifikante Schwäche der Atemmuskulatur bei unkontrolliertem Asthma

  • P 162
    Smith, J; Mcgarvey, L; Alyn, H M; Sher, M; Kardos, P; Garin, M; Yang, R; Bonuccelli, C:

    Prior and concomitant medication use in patients with refractory chronic cough: post-hoc analysis of SOOTHE

  • P 169
    Devouassoux, G; Jackson, D; Käßner, F; Caruso, C; Shavit, A; Olinger, L; Menzies-Gow, A:

    Clinical remission in patients with severe eosinophilic asthma treated with benralizumab who were randomised to reduce their inhaled corticosteroid/formoterol dose: SHAMAL post-hoc analysis

  • P 176
    Jackson, D; Käßner, F; Menzies-Gow, A; Shavit, A; Olinger, L; Di Marco, F; Devouassoux, G:

    Factors influencing lung function changes when inhaled corticosteroid/formoterol is reduced in patients with severe eosinophilic asthma treated with benralizumab

  • FV 207
    Lenoir, A; Buhl, R; Mümmler, C; Behr, J; Holtdirk, A; Ehmann, R; Hamelmann, E; Idzko, M; Jandl, M; Kässner, F; Schmidt, O; Schulz, C; Skowasch, D; Taube, C; Korn, S; Milger-Kneidinger, K:

    Choosing and switching biologics for patients with severe asthma – real life data from the German Asthma Net

  • P 226
    Herth, F; Schreiber, J; Mokros, I; Schwitalla, J; Vetter, C:

    Versorgung von Patient*innen mit unkontrolliertem Asthma in Deutschland mit Fokus auf die KV Regionen Magdeburg (MD) und Mannheim (MA)

  • P 244
    Trinkmann, F; Bogoevska, V; Fritz, C; Wendt, A; Ruether, L; Zache, P; Schriever, M; Gessner, C:

    Effect on Asthma Control and Quality of Life in Asthma with Pre-bronchodilator Airflow Limitation prior to Initiation of Fixed Triple Therapy Consisting of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium (BDP/FF/G): Six-Month Follow-up of the TriMaximize Study

  • P 248
    Reshetnykova, T; Seefeldt, M; Milger-Kneidinger, K; Skowasch, D; Schulz, C; Jandl, M; Ehmann, R; Kässner, F; Taube, C; Hamelmann, E; Buhl, R; Idzko, M; Korn, S:

    Charakteristika schwerer Asthmatiker in den alten versus neuen Bundesländern im German Asthma Net

  • P 253
    Gessner, C; Bogoevska, V; Martini, M; Jeromin, J; Borucki, T; Bartelt, M; Hahn, A; Trinkmann, F:

    Effects on Sleep, Tolerability and Patient Satisfaction of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium in Asthma Patients: Six-Month Follow-up of the TriMaximize Study

  • Po 254
    Greulich, T; Bogoevska, V; Akyildiz, B; Slawinska, R; El-Serri, K; Ladopoulos, A; Grickschat, V; Gessner, C:

    Safety of Fixed Triple Therapy with Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium (BDP/FF/G) in Patients with Asthma: Six-Month Real-World Evidence of the TriMaximize Study

  • FV 340
    Bal, C; Zehetmayer, S; Stoshikj, S; Milger-Kneidinger, K; Skowasch, D; Schulz, C; Jandl, M; Schmidt, O; Taube, C; Hamelmann, E; Buhl, R; Korn, S; Idzko, M:

    The German Asthma Net: Weight loss predictors in severe asthma with obesity or overweight

  • FV 362
    Lommatzsch, M; Mülleneisen, N; Milger-Kneidinger, K; Skowasch, D; Schulz, C; Körner-Rettberg, C; Ehmann, R; Kässner, F; Taube, C; Hamelmann, E; Buhl, R; Idzko, M; Korn, S:

    Schweres Asthma bei Älteren: Daten aus dem German Asthma Net (GAN) Register

  • P 368
    Lommatzsch, M; Korn, S; Schmidt, O; Timmermann, H; Gappa, M; Watz, H; Nischan, N; Hahn, M; Heimann, A:

    Schweres Asthma nach 2 Jahren der Dupilumab-Therapie: Real-World-Daten aus der ProVENT-Studie

  • P 370
    Trinkmann, F; Greulich, T; Schwitalla, J; Vierbuchen, T:

    Regionale Ungleichheiten in der Versorgung von schwerem Asthma in Deutschland – Daten aus ATLAS Asthma

  • P 381
    Götschke, J; Spiro, J; Walter, J; Götschke, M; Gerckens, M; Mümmler, C; Mertsch, P; Dinkel, J; Behr, J; Milger-Kneidinger, K:

    Klinische Remission bei schwerem Asthma: Prävalenz und Einflussfaktoren in einer Real-World-Kohorte

  • P 386
    Washko, G; Lommatzsch, M; Lipworth, B; Saralaya, D; Zhang, M; Soler, X; Sacks, H; Deniz, Y; Rowe, P; De Prado Gomez, L; Jacob-Nara, J:

    Effect of Dupilumab on Airway Oscillometry, Ventilation/Perfusion, and Mucus Plugging in Moderate-to-Severe Asthma: the VESTIGE Trial

  • P 387
    Wechsler, M; Buhl, R; Jackson, D; Rabe, K; Pavord, I; Virchow, J; Katial, R; Israel, E; Xia, C; Soliman, M; Pandit-Abid, N; Jacob-Nara, J; Sacks, H; Rowe, P; Deniz, Y:

    Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study

  • P 400
    Chalmers, J; Shteinberg, M; Mall, M; O'Donnell, A; Watz, H; Gupta, A; Frahm, E; Eleftheraki, A; Rauch, J; Chotirmall, S; Armstrong, A; Eickholz, P; Hasegawa, N; Sauter, W; McShane, P:

    Results from a Phase II trial (AIRLEAF) of a cathepsin C (dipeptidyl peptidase 1) inhibitor, BI 1291583, in adults with non-cystic fibrosis bronchiectasis*

  • FV 414
    Sander, S; Bratke, K; Jaishankar, N; Stoll, P; Virchow, J; Lommatzsch, M:

    Kostimulatorische Moleküle auf dendritischen Zellen von Patienten mit schwerem Asthma: Einfluss von Biologika-Therapien

  • P 446
    Zielen, S; Bernstein, J; Berger, U; Berger, M; Mösges, R; Cuevas, M; Shamji, M; Dubuske, L; Seybold, M; Kramer, M; Skinner, M; DeKam, P:

    Positive outcome of the pivotal Phase III study with PQ Grass 27600 SU, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine (MCT) and Monophosphoryl Lipid A (MPL) as adjuvant system

  • P 449
    Zielen, S; Cuevas, M; DeKam, P; Kramer, M; Skinner, M; Sellwood, F:

    Meta-analysis of primary endpoint of Grass MATA MPL field studies with optimized dose and treatment regimen of PQ Grass 27600 SU

  • FV 512
    Mümmler, C; Lenoir, A; Götschke, J; Gerckens, M; Hinze, C; Kaiser, M; Drick, N; Suhling, H; Biener, L; Pizarro, C; Skowasch, D; Behr, J; Kneidinger, N; Milger-Kneidinger, K:

    Langzeit-Outcomes unter Dupilumab – eine retrospektive, multicenter, real-world Studie

  • P 514
    Milger-Kneidinger, K; Gessner, C; Wehgartner-Winkler, S; Timmermann, H; Urbanski, H; Llanos, J; Natman, J; Martin, N; Emmanuel, B; Clarke, D; Le, T; Stjepanovic, N; Koch, M; Schwitalla, J:

    Real-World Daten zur Asthmakontrolle über 24 Wochen bei deutschen Patienten mit schwerem, unkontrolliertem Asthma, die mit Tezepelumab behandelt wurden: Zwischenanalyse aus der ASCENT-Studie

  • P 569
    Hinze, C; Biener, L; Skowasch, D; Mümmler, C; Milger-Kneidinger, K; Fuge, J; Valtin, C; Suhling, H; Drick, N:

    Ursachen eines Therapieabbruch von Tezepelumab bei Patienten mit schwerem Asthma